The EORTC Genito-Urinary Tract Cancer Group: 25 years of achievements and future strategies.
The European Organisation for Research and Treatment of Cancer (EORTC) Genito-Urinary (GU) Tract Cancer Group celebrates 25 years of activity in 2001. The Group has developed an intense research activity carrying out phase II and phase III clinical trials in prostate, bladder, renal, penile and testicular cancers. It is one of the most active groups within the EORTC, entering more than 1200 new patients in its trials in 2001. In its trials, the EORTC GU Group also focuses on quality control, quality of life and uro-pathology. Besides collaboration with other EORTC groups, the GU Group is very actively collaborating with international organisations. Currently, several large phase III studies are conducted in collaboration with European and North American organisations. For the next few years, the Group is committed to develop projects aimed at testing new drugs and therapeutic strategies and increasing the collaboration between basic science and clinical practice.
Bono
A
A
Department of Urology, Ospedale di Circolo e Fondazione Macchi, Viale Borri 57, 21100, Varese, Italy.
Zurlo
A
A
D002986:Clinical Trials as Topic / Q000639:trends; D005060:Europe; D005544:Forecasting; D006801:Humans; D007390:International Agencies / Q000639:trends*; D008495:Medical Oncology / Q000639:trends*; D012106:Research / Q000639:trends*; D014565:Urogenital Neoplasms / Q000628:therapy*